Global Acute Ischemic Stroke Therapeutics Market 2024-2028
상품코드:1626923
리서치사:TechNavio
발행일:2024년 09월
페이지 정보:영문 184 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
급성허혈성 뇌졸중 치료 시장, 2024-2028년
급성허혈성 뇌졸중 치료 시장은 2023-2028년에 17억 4,200만 달러, 예측 기간 중 CAGR은 6.1%로 성장할 것으로 예측됩니다. 급성허혈성 뇌졸중 치료 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 시장은 심혈관 질환의 유병률 증가, 직접 경구용 항응고제의 채택 증가, 좌식 생활습관의 유병률 증가에 의해 주도되고 있습니다.
시장 범위
기준연도
2024년
종료연도
2028년
예측 기간
2024-2028년
성장 모멘텀
가속
전년 대비(2024년) 대비
5.7%
CAGR
6.1%
증분액
17억 4,200만 달러
이 보고서는 급성 허혈성 뇌졸중 관리에 있으며, 유전체 데이터와 임상 데이터의 통합을 통한 번역 생물정보학을 통한 급성 허혈성 뇌졸중 관리가 향후 수년간 급성 허혈성 뇌졸중 치료 시장 성장을 촉진하는 주요 요인 중 하나라고 밝혔습니다. 또한 유전체 의학의 출현과 급성 허혈성 뇌졸중 치료제의 강력한 파이프라인이 시장의 큰 수요를 견인할 것으로 예상했습니다.
The acute ischemic stroke therapeutics market is forecasted to grow by USD 1742 mn during 2023-2028, accelerating at a CAGR of 6.1% during the forecast period. The report on the acute ischemic stroke therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cardiovascular diseases, increasing adoption of direct oral anticoagulants, and increasing prevalence of sedentary lifestyles.
Market Scope
Base Year
2024
End Year
2028
Series Year
2024-2028
Growth Momentum
Accelerate
YOY 2024
5.7%
CAGR
6.1%
Incremental Value
$1742 mn
Technavio's acute ischemic stroke therapeutics market is segmented as below:
By Type
Thrombolytics
Anticoagulants
Antiplatelets
Antihypertensives
Others
By Distribution Channel
Hospital pharmacies
Retail pharmacies
Online pharmacies
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the integrating genomic and clinical data through translational bioinformatics in acute ischemic stroke management as one of the prime reasons driving the acute ischemic stroke therapeutics market growth during the next few years. Also, advent of genomic medicine and strong pipeline of acute ischemic stroke therapeutics will lead to sizable demand in the market.
The report on the acute ischemic stroke therapeutics market covers the following areas:
Acute Ischemic Stroke Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading acute ischemic stroke therapeutics market vendors that include Amgen Inc., AstraZeneca Plc, Athersys Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., Medtronic PLC, Merck and Co. Inc., NoNO Inc., Pfizer Inc., SanBio Co. Ltd., Sanofi SA, Stryker Corp., and Teva Pharmaceutical Industries Ltd.. Also, the acute ischemic stroke therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Acute Ischemic Stroke Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Acute Ischemic Stroke Therapeutics Market 2018 - 2022 ($ million)
